Lymphopenia and eosinophilia in dimethyl fumarate treated patients

被引：0
|
作者：
Vinagre Aragon, A. [1 ]
Garcia Malo, C. [1 ]
Novo Ponte, S. [1 ]
Mena Romo, L. [1 ]
Moreno Torres, I. [1 ]
Blasco Quilez, M. R. [1 ]
Garcia Merino, A. [1 ]
机构：
[1] Hosp Puerta de Hierro, Neurol, Madrid, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1236
引用
收藏
页码：651 / 651
页数：1
相关论文
共 50 条
  • [1] Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
    Nakhaei-Nejad, Maryam
    Barilla, David
    Lee, Chieh-Hsin
    Blevins, Gregg
    Giuliani, Fabrizio
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (02):
  • [2] Age influences lymphopenia in MS patients treated with dimethyl-fumarate
    Mancinelli, C. R.
    Scarpazza, C.
    Rasia, S.
    De Rossi, N.
    Cordioli, C.
    Capra, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 506 - 507
  • [3] Real world experience of lymphopenia in MS patients treated with dimethyl fumarate
    Romba, M.
    Gallaro, D.
    Wundes, A.
    von Geldern, G.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 587 - 587
  • [4] Longitudinal Data on Lymphopenia in Multiple Sclerosis Patients Treated with Dimethyl Fumarate
    Romba, Meghan
    Wundes, Annette
    Von Geldern, Gloria
    NEUROLOGY, 2016, 86
  • [5] Predictive factors of lymphopenia in a young cohort of Multiple Sclerosis patients treated with Dimethyl Fumarate
    Krupka, Danna
    Ferreira, Vitor Mendes
    Correia, Ana Sofia
    Teixeira, Manuel Salavisa
    Serrazina, Filipa
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 971 - 971
  • [6] Assessment of lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate in a real clinical setting
    Alroughani, R.
    Ahmed, S.
    Behbehani, R.
    Al-Hashel, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 593 - 593
  • [7] Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis
    Ravn, Julie
    Jensen, Henrik Boye
    Kant, Matthias
    Andersen, Preben Borring
    Gora, Monika Katarzyna
    Sejbaek, Tobias
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
  • [8] Risk factors for Development of Lymphopenia in Dimethyl Fumarate-treated Patients with Multiple Sclerosis
    Bloch, Caroline Holst
    Sejbaek, Tobias
    Kant, Matthias
    Blaabjerg, Morten
    Jensen, Henrik Boye
    Andersen, Preben
    Petersen, Annett
    Gora, Monika
    NEUROLOGY, 2019, 92 (15)
  • [9] Lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate: A single-center experience
    Dinoto, Alessandro
    Sartori, Arianna
    Cheli, Marta
    Pasquin, Fulvio
    Baldini, Sara
    Bratina, Alessio
    Bosco, Antonio
    Manganotti, Paolo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [10] Assessment of lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate in a real clinical setting
    Alroughani, Raed
    Ahmed, Samar
    Behbehani, Raed
    Al-hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP18 - NP18
12345